Automated description from the Alliance of Genome Resources
Predicted to have guanylate cyclase inhibitor activity; protein C-terminus binding activity; and ubiquitin-specific protease binding activity. Predicted to be involved in negative regulation of cGMP-mediated signaling. Localizes to several cellular components, including the apical part of cell; brush border; and cytoplasm. Orthologous to human PDZD3 (PDZ domain containing 3).